Pressure-controlled versus volume-controlled ventilation for acute respiratory failure: uncertain if there is an important difference in outcomes
Citation: Chacko B, Peter J V, Tharyan P, et al. Pressure-controlled versus volume-controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). Cochrane Database of Systematic Reviews 2015; (1): CD008807
What is this? Some patients with COVID-19 will develop respiratory failure and need help with their breathing. This might be provided by mechanical ventilation (MV) in an intensive care unit (ICU), but this can cause complications. Techniques used to prevent these complications are different ways for controlling the pressure or volume of air delivered by MV.
In this Cochrane systematic review, the authors searched for randomized and quasi-randomized trials which compared pressure-controlled ventilation (PCV) versus volume-controlled ventilation (VCV) in adults with acute respiratory failure. They did not restrict by language or publication status and did their searches in October 2014. They identified three randomized trials (1089 participants).
What works: Nothing noted.
What doesn’t work: Nothing noted.
What’s uncertain: It is uncertain if there is a difference between PCV and VCV for the following outcomes, for adults with acute respiratory failure: mortality in the ICU, barotrauma, duration of MV, infection during MV or quality of life after discharge.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.